Cargando…
Which One to Endorse Among the Multitude of Lipid Guidelines?
Dyslipidemia is the major risk factor for atherosclerotic cardiovascular diseases. A multitude of lipid guidelines exist, with several controversies, and the best approach in dyslipidemia management is not clear. The tools and lipoproteins used for risk assessment, whether to use a treatment target...
Autor principal: | Sonmez, Alper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Touch Medical Media
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819059/ https://www.ncbi.nlm.nih.gov/pubmed/29632564 http://dx.doi.org/10.17925/EE.2015.11.01.32 |
Ejemplares similares
-
Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
por: Karlsson, Sofia Axia, et al.
Publicado: (2019) -
High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease
por: Zuber, Verena, et al.
Publicado: (2020) -
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019) -
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019) -
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines
por: Elsinga, Philip, et al.
Publicado: (2019)